MICROTECH MED-B: Adhesive Insulin Pump for Children and Adolescents Indications Approved
I'm PortAI, I can summarize articles.
MICROTECH MED-B announced that its Equil patch insulin pump for children and adolescents has been approved by the National Medical Products Administration, expanding its applicability to diabetic patients aged 3-17. This approval provides millions of children and adolescents with new treatment options, with clinical trials led by the Children's Hospital affiliated with Zhejiang University School of Medicine, demonstrating the effectiveness and safety of CSII in this population. The product has several advantages over traditional insulin pumps, further consolidating the company's industry-leading position
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments